U.S. wants to test Ebola vaccine on humans
The U.S. government tested an experimental Ebola vaccine on primates earlier this week, from which they said they saw positive results. Now, the government said they may begin testing the vaccine on people as soon as next month.
The National Institutes of Health (NIH) is working with the U.S. Food and Drug Administration (FDA) to start trials of the Ebola vaccine.
Development of the vaccine comes after two Americans in Africa were recently infected with Ebola. The virus infection has been widespread in Guinea, Sierra Leone, Liberia and Nigeria, in which a total of 1,323 suspected cases of the disease have been confirmed, according to the World Health Organizaiton (WHO). More than 700 people have died to date.
There is no known cure for Ebola and although the outbreak has been confined to West Africa, there are concerns that it can spread through travel. Symptoms can take anywhere from two to 21 days to appear.
Earlier this week, the Centers for Disease Control warned against any nonessential travel to West African regions.